Hennion & Walsh Asset Management’s Procept Biorobotics PRCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-10,343
Closed -$259K 999
2026
Q1
$259K Sell
10,343
-210
-2% -$5.92K 0.01% 856
2025
Q4
$332K Buy
10,553
+7
+0.1% +$232 0.01% 805
2025
Q3
$376K Sell
10,546
-89
-0.8% -$4.06K 0.01% 783
2025
Q2
$613K Buy
10,635
+278
+3% +$15.7K 0.02% 616
2025
Q1
$603K Buy
10,357
+733
+8% +$50K 0.03% 586
2024
Q4
$775K Buy
9,624
+3,702
+63% +$316K 0.04% 524
2024
Q3
$474K Buy
5,922
+1,273
+27% +$90.4K 0.02% 634
2024
Q2
$284K Buy
+4,649
New +$276K 0.01% 741

Other funds holding PRCT